Cargando…
BRD4 facilitates DNA damage response and represses CBX5/Heterochromatin protein 1 (HP1)
Ovarian cancer (OC) is a heterogeneous disease characterized by defective DNA repair. Very few targets are universally expressed in the high grade serous (HGS) subtype. We previously identified that CHK1 was overexpressed in most of HGSOC. Here, we sought to understand the DNA damage response (DDR)...
Autores principales: | Pongas, Georgios, Kim, Marianne K., Min, Dong J., House, Carrie D., Jordan, Elizabeth, Caplen, Natasha, Chakka, Sirisha, Ohiri, Joyce, Kruhlak, Michael J., Annunziata, Christina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584257/ https://www.ncbi.nlm.nih.gov/pubmed/28881656 http://dx.doi.org/10.18632/oncotarget.17572 |
Ejemplares similares
-
Identification of therapeutic targets applicable to clinical strategies in ovarian cancer
por: Kim, Marianne K., et al.
Publicado: (2016) -
Biophysical Properties of HP1-Mediated Heterochromatin
por: Sanulli, Serena, et al.
Publicado: (2019) -
YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNA
por: Kloetgen, Andreas, et al.
Publicado: (2020) -
Overlapping domains of the heterochromatin-associated protein HP1 mediate nuclear localization and heterochromatin binding
Publicado: (1993) -
Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins
por: LeRoy, Gary, et al.
Publicado: (2012)